About 6,500 out of about 2.7 of the recipients of the first dose and about 3,500 out of about 1.3 million in the second dose reported side effects • About half of them were local • Full data
A man gets vaccinated in Jerusalem (the photographer has nothing to do with the news)
Photography:
Oren Ben Hakon
The Ministry of Health today (Monday) published a report on the side effects found among the vaccine vaccines against the corona in the first and second injections.
According to the ministry's announcement, as part of the first dose, 6,575 people reported side effects out of 2,768,200 vaccines. Side effects 3,592 people out of 1,377,827 vaccinated. The authors of the report noted that it was interesting to find that women and young people were more likely to report side effects, relative to their share in the percentage of vaccine recipients.
In general, the report states that the reported side effects are similar to those that occur in cases of other vaccines given to the population, and that in the vast majority of cases they were mild and transient. In fact, according to the data, about half of those reported (3,307) experienced local side effects.
The full report
The rest of the cases were general manifestations of physical weakness, which were reported by 2,756 people during the first dose.
The first injection, however, had unusual effects: 287 vaccinators reported neurological symptoms, 165 suffered from allergies and anaphylaxis (a life-threatening allergic reaction), with only 60 people out of the dose receiving suffering from other unusual or requiring further side effects.
The population began to be vaccinated in the second dose // Archive photo: Moshe Ben Simhon and Newsenders
In relation to the second dose, a relatively similar picture emerges here as well: 799 people suffered from local symptoms in the injection area and 2,631 people suffered from general weakness and symptoms that are also present in other vaccines.
Regarding neurological symptoms or reactions, only 96 people reported and / or experienced such symptoms.
Only 47 vaccinators suffered from allergies and anaphylaxis, and only 19 suffered from other significant symptoms or those requiring further follow-up.
Examining the reports, it turns out that the age group whose members reported the most side effects is 60-40.
They were reportedly 39-20 years old.
Both of these groups include the vast majority of those who suffered from side effects, with a small group of people aged 60 and over experiencing this as well.
The group that reported almost no side effects were people under the age of 20 (who also had almost no partner in the current vaccination campaign).
What side effects have been reported?
Local responses
Regarding local reactions at the injection site, the vast majority of reports in both the first and second dose were of pain at the injection site.
In a very wide gap, a small minority of people reported redness or swelling and less so difficulty in movement.
There have been some reports of local discoloration, enlargement of the lymph nodes, subcutaneous contact, local inflammation, local rash, itching or wound with pus.
The general phenomena
Regarding general symptoms, the vast majority of reports in both the first and second dose were general weakness in the body.
Then, in second place, there were headaches.
However, 92.3 people per million reported dizziness and fainting after the first dose.
In the second dose, 317.9 million people reported fever, 210.5 million reported muscle pain, and 140.1 million reported joint pain.
In general, after the second dose, symptoms such as muscle aches, fever and joint pain were lower than 60 people per million people.
In contrast, after the second dose people also reported dizziness and fainting (103.8 per million people) and chills (87.1 per million people).
Symptoms with a very low incidence in both doses: vomiting / nausea, sore throat, runny nose and cough and diarrhea and loss of appetite.
Reported allergies
When it comes to allergy reports, most reporters in the first and second dose reported a general feeling of allergy.
In second place were reports of itching (6.1 people per million), urticaria (hives) which is an allergy of the skin (3.6 people per million), difficulty breathing (2.9 per million), while in relation to the onset of anaphylaxis the rate stands at 1.4 people per million people.
Other effects were swelling of the upper respiratory tract (0.7 million), rapid pulse (1.4 million), rash (1.8 million), tingling sensation (2.2 million), angioedema (edema of the subcutaneous tissue), local or diffuse (1.4 million).
Neurological effects
The main neurological phenomenon reported was circumcision in areas of the body.
In the first dose, 180 people reported the phenomenon and in the second dose, 69 reported it. Other neurological diagnoses were found in 29 vaccinated people after the first dose and 8 after the second dose.
Physicalis (facial nerve palsy) was reported by 30 people after the first dose and by one person after the second dose.
11 people reported seizures after the first dose alone.
Two people lost consciousness after the first dose, four suffered from a transient ischemic event (stroke lasting a few minutes) after the first dose and one after the second dose.
11 suffered after the first dose from a metallic mouth and eight suffered from it after the second dose.
It should be noted that some people have reported more than one phenomenon and that the information is as of January 27th.